Form Bio Blog

Updates and perspectives from our industry experts, scientists and product leaders.

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.

Featured

Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Featured

Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Featured

Cell and Gene Therapy

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

Leveraging large language models has proven to shorten the development time of gene therapies. Learn more here.

Featured

Computational Life Sciences

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

Recent published research is bringing us one step closer to predicting molecular phenotypes from a DNA sequence. Read this blog to learn more.

Featured

Cell and Gene Therapy

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Jill Roughan, PhD

February 1, 2023

As gene therapy becomes more prevalent, so too do the challenges associated with ensuring its safety. Learn how to manufacture the purest and most potent AAV based gene therapy.

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Featured

Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

Nick Ketz, PhD

January 31, 2023

DeepMind researchers released a large language model (LLM) that uses fewer parameters yet achieves better performance. Read more to understand how this is relevant to your gene therapy programs.

Featured

Cell and Gene Therapy

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development

Claire Aldridge, PhD

January 17, 2023

Why are natural history studies important in cell and gene therapy development? Hear from our Chief Strategy Officer, Claire Aldridge, PhD on the importance of these studies and the need for effective data capture to make the most of them.

Featured

Computational Life Sciences

The Biologist’s Introduction to Computational Life Sciences

Jill Roughan, PhD

December 27, 2022

Read here for an introduction to the emerging field of computational life sciences and its broad impact and applications in solving challenging research and clinical problems.

Featured

Computational Life Sciences

How Computational Life Sciences Enables Metagenomics Studies

Jill Roughan, PhD

December 13, 2022

Metagenomics studies and sophisticated computational tools advance disciplines from basic research to healthcare. Find out more in our blog.

Featured

Cell and Gene Therapy

Guest Post: What 2023 Holds for Cell and Gene Therapy

ChatGPT

December 7, 2022

With AI becoming not just inextricable but central for both science and software, we thought it fitting and worthwhile to utilize creative AI tools to see what 2023 might have in store for cell and gene therapy. Hence, our guest author is none other than OpenAI's ChatGPT.

Featured

Cell and Gene Therapy

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research

Jill Roughan, PhD

November 29, 2022

The ability to interpret data is crucial to advancing cell and gene therapy research. Read on to hear how researchers are presenting data in an accessible way.

Using Deep Learning in Cell & Gene Therapy

Featured

Cell and Gene Therapy

Using Deep Learning in Cell & Gene Therapy

Jill Roughan, PhD

November 15, 2022

The power of deep learning for discovering and developing cell and gene therapies is undeniable. Learn how to implement it with these 10 actionable tips.

Featured

Computational Life Sciences

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data

Jill Roughan, PhD

November 8, 2022

Sequencing technologies have seen many remarkable innovations over the last decade and shows no signs of slowing down. Read here for emerging trends.

Hear from Karlie, Our Senior Engineer, on Driving DEIB in Tech

Featured

Computational Life Sciences

Hear from Karlie, Our Senior Engineer, on Driving DEIB in Tech

Jill Roughan, PhD

October 25, 2022

Hear from Karlie, our Senior Engineer, on driving diversity, equity, inclusion and belonging (DEIB) in tech and more.

Opportunities and Challenges in Bioinformatics Software

Featured

Computational Life Sciences

Opportunities and Challenges in Bioinformatics Software

Jill Roughan, PhD

October 20, 2022

Deciding between purchasing bioinformatics software or building your own pipeline? Check out the opportunities and challenges of each.

Top 5 Take-aways from the 2022 iC3 Life Science Summit

Featured

Computational Life Sciences

Top 5 Take-aways from the 2022 iC3 Life Science Summit

Claire Aldridge, PhD

October 3, 2022

Did you miss the 2022 iC3 Life Science Summit? No worries, read here for the top take-aways by Form’s Chief Strategy Officer.

Form Bio Resources

Cell and Gene Therapy

Leveraging AI Models To Improve Safety of Gene Therapy

Nick Ketz, PhD

May 3, 2023

Learn how predictive modeling can generate synthetic regulatory sequences for safer and more efficacious gene therapies.

Computational Life Sciences

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Sasha Maslova

April 18, 2023

Get insights from Sasha, our Artificial Intelligence (AI) Scientist, on a newly published article describing the potential undesirable effects of synonymous codon substitution and the role of computational methods to overcome these challenges.

Cell and Gene Therapy

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Austin Day, PhD

March 22, 2023

Continuing our blog series on Transformer architectures and their use in gene therapy applications, we explore the latest variants’ size and speed improvements.

Board of Directors

Johnnn

Doe

,

Ph.D.

CEO

Johnn

Doe

,

Ph.D.

CEO

John

Doe

,

Ph.D.

CEO

Johnnn

Doe

,

Ph.D.

CEO

Form Bio Resources

Cell and Gene Therapy

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Cell and Gene Therapy

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.

Cell and Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.

Form Bio Blog

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

Leveraging AI Models To Improve Safety of Gene Therapy

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing

Shortening Gene Therapy Development Time with Strategic Use of Large Language Models

New Study Finds Large Language Models Applied to DNA Sequences Enabled Accurate Molecular Phenotype Prediction

How Top Biotechs Use Deep Learning to Drive Development of Cell and Gene Therapy

Understanding How Best to Allocate Resources When Training Large Language Models in Gene Therapy Development Programs

How to leverage natural history studies to fill knowledge gaps in cell and gene therapy development

The Biologist’s Introduction to Computational Life Sciences

How Computational Life Sciences Enables Metagenomics Studies

Guest Post: What 2023 Holds for Cell and Gene Therapy

Applying Data Visualization Tools to Advance Cell and Gene Therapy Research

Using Deep Learning in Cell & Gene Therapy

Sequencing and Computational Life Sciences: Making Sense of Big Genomic Data

Hear from Karlie, Our Senior Engineer, on Driving DEIB in Tech

Opportunities and Challenges in Bioinformatics Software

Top 5 Take-aways from the 2022 iC3 Life Science Summit

Form Bio Resources

Leveraging AI Models To Improve Safety of Gene Therapy

Maximizing Therapeutic Efficacy Through Codon Substitution Design

Exploring the Versatility of the Latest Transformer Architecture Variants and Their Implications for Gene Therapy Developers

Board of Directors

Johnnn

Doe

,

Ph.D.

Johnn

Doe

,

Ph.D.

John

Doe

,

Ph.D.

Johnnn

Doe

,

Ph.D.

Form your future breakthroughs

See how Form can empower you

Get informed

Form Bio Resources

De-Risking Gene Therapy Biomanufacturing Early to Unlock Late-Stage Success and Cost Savings

The Power of Integrating Single-Cell Multi-Omic Analysis to Accelerate Cell and Gene Therapy Biomanufacturing

Form Bio Applauds The White House’s New Goals and Priorities Promoting Growth of Domestic Cell and Gene Therapy Biomanufacturing